Literature DB >> 10911923

Peripheral opioid modulation of visceral pain.

G F Gebhart1, X Su, S Joshi, N Ozaki, J N Sengupta.   

Abstract

Opioids are widely and successfully used for control of pain, including pain arising from the viscera. Constipating, sedating, respiratory depressant and other effects of opioids, however, often limit their long-term use in the treatment of a variety of visceral pain states. Accordingly, understanding visceral pain mechanisms and its modulation is important to developing improved strategies for pain control.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10911923     DOI: 10.1111/j.1749-6632.2000.tb06675.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

1.  Evaluation of the peripheral analgesic effect of sufentanil lipid nanoparticles.

Authors:  Hongjun Li; Hui Qiao; Hongjie Lu; Changqi Liu
Journal:  J Anesth       Date:  2014-03-07       Impact factor: 2.078

Review 2.  Kappa opioids and the modulation of pain.

Authors:  Bronwyn Kivell; Thomas E Prisinzano
Journal:  Psychopharmacology (Berl)       Date:  2010-04-07       Impact factor: 4.530

3.  Inhibition of P2X7 receptors by Lu AF27139 diminishes colonic hypersensitivity and CNS prostanoid levels in a rat model of visceral pain.

Authors:  Roland G W Staal; Adarsh Gandhi; Hua Zhou; Manuel Cajina; Anne-Marie Jacobsen; Sara Hestehave; Allen Hopper; Suresh Poda; Gamini Chandresana; Stevin H Zorn; Brian Campbell; Marta Segerdahl; Thomas Mӧller; Gordon Munro
Journal:  Purinergic Signal       Date:  2022-08-24       Impact factor: 3.950

Review 4.  Peptide kappa opioid receptor ligands: potential for drug development.

Authors:  Jane V Aldrich; Jay P McLaughlin
Journal:  AAPS J       Date:  2009-05-09       Impact factor: 4.009

5.  Drug management of visceral pain: concepts from basic research.

Authors:  Mellar P Davis
Journal:  Pain Res Treat       Date:  2012-04-24

6.  Inhibition of visceral nociceptors.

Authors:  David E Reed; L Ashley Blackshaw
Journal:  Front Pharmacol       Date:  2014-04-14       Impact factor: 5.810

7.  Peripheral antinociceptive effects of a bifunctional μ and δ opioid receptor ligand in rat model of inflammatory bladder pain.

Authors:  Maia Terashvili; Bhavana Talluri; Watchareepohn Palangmonthip; Kenneth A Iczkowski; Patrick Sanvanson; Bidyut K Medda; Banani Banerjee; Christopher W Cunningham; Jyoti N Sengupta
Journal:  Neuropharmacology       Date:  2021-07-10       Impact factor: 5.273

Review 8.  The Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A Review.

Authors:  MahmoudReza Khansari; MasourReza Sohrabi; Farhad Zamani
Journal:  Middle East J Dig Dis       Date:  2013-01

Review 9.  Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome.

Authors:  Aleksandra Sobolewska-Włodarczyk; Marcin Włodarczyk; Martin Storr; Jakub Fichna
Journal:  Ther Clin Risk Manag       Date:  2016-05-13       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.